UniProt/SwissProt ID: | PK3CG_HUMAN |
Description: | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma [Source:HGNC Symbol;Acc:8978] |
Location: | chr7 q22.3 |
Node attribute: | kinase; effector; substrate |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
S1101 | QGEKH | HPRD | |
T607 | EIVAKtYQLLA | PI3Ka | PhosphoSitePlus |
S620 | EVWDQsALDVG | PI3Ka | PhosphoSitePlus |
S1101 | QGEKH | PIK3CG | phosphoELM |
Y757 | LSAEKyDVSSQ | PhosphoSitePlus | |
T250 | LQSFFtKMAKK | PI3K_rbd | PhosphoSitePlus |
S1101 | QGEKHsA | RegPhos | |
T1024 | ALRHHtNLLII | PI3_PI4_kinase | PhosphoSitePlus |
T627 | LDVGLtMQLLD | PI3Ka | PhosphoSitePlus |
S230 | HRSTTsQTIKV | PI3K_rbd | PhosphoSitePlus |
T228 | VIHRStTSQTI | PI3K_rbd | PhosphoSitePlus |
S227 | IVIHRsTTSQT | PI3K_rbd | PhosphoSitePlus |
T229 | IHRSTtSQTIK | PI3K_rbd | PhosphoSitePlus |
S1101 | QGEKHsA____ | PhosphoSitePlus | |
S1101 | QGEKHsA | PIK3R4 | RegPhos |
S636 | LDCNFsDENVR | PI3Ka | PhosphoSitePlus |
Dephosphorylation site |
PK3CG_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000419260 | R552C | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000392258 | E511K | COSMIC | Lung Cancer | |
ENSP00000392258 | R18Q | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000352121 | E602V | COSMIC | Lung Cancer | 20668451 |
ENSP00000352121 | S760R | TCGA | Ovarian Cancer | 21720365, 18772890 |
ENSP00000392258 | E740K | COSMIC | Breast Cancer | 20668451 |
ENSP00000392258 | T1024K | TCGA | Neoplasms by Histologic Type | 21720365, 18772890 |
ENSP00000392258 | E602V | COSMIC | Lung Cancer | 20668451 |
ENSP00000392258 | L379I | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000419260 | K52* | COSMIC | Lung Cancer | 18948947 |
ENSP00000419260 | T1024K | TCGA | Neoplasms by Histologic Type | 21720365, 18772890 |
ENSP00000419260 | P563R | COSMIC | Lung Cancer | 18948947 |
ENSP00000392258 | K52* | COSMIC | Lung Cancer | 18948947 |
ENSP00000419260 | L843H | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000352121 | K364N | COSMIC | Lung Cancer | 20668451 |
ENSP00000392258 | G491E | COSMIC | Head and Neck Cancer | 21798897 |
ENSP00000392258 | A445S | TCGA | Ovarian Cancer | 21720365, 18772890 |
ENSP00000392258 | P1004L | TCGA | Neoplasms by Histologic Type | 21720365, 18772890 |
ENSP00000352121 | G966W | Ding2008, COSMIC | Lung Cancer | 18948947 |
ENSP00000352121 | R21W | BIOMART | Hepatocellular Carcinoma | 21930507, 21930502 |
ENSP00000352121 | K52* | Ding2008, COSMIC | Lung Cancer | 18948947 |
ENSP00000352121 | S760R | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000419260 | L58M | COSMIC | Lung Cancer | 18948947 |
ENSP00000392258 | R178L | COSMIC | Lung Cancer | 20668451 |
ENSP00000352121 | T1024K | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000419260 | V616D | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000352121 | P563R | Ding2008, COSMIC | Lung Cancer | 18948947 |
ENSP00000419260 | R178L | COSMIC | Lung Cancer | 20668451 |
ENSP00000352121 | S348I | COSMIC | Lung Cancer | 20668451 |
ENSP00000419260 | L379I | TCGA | Ovarian Cancer | 21720365, 18772890 |
ENSP00000419260 | S353F | COSMIC | Skin Cancer | 21984974 |
ENSP00000419260 | C936S | TCGA | Neoplasms by Histologic Type | 21720365, 18772890 |
ENSP00000352121 | T503M | COSMIC | Breast Cancer | 20668451 |
ENSP00000419260 | K364N | COSMIC | Lung Cancer | 20668451 |
ENSP00000352121 | R18Q | TCGA | Neoplasms by Histologic Type | 21720365, 18772890 |
ENSP00000352121 | A445S | TCGA | Ovarian Cancer | 21720365, 18772890 |
ENSP00000392258 | R552C | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000352121 | D161E | COSMIC | Lung Cancer | 20668451 |
ENSP00000419260 | A445S | TCGA | Ovarian Cancer | 21720365, 18772890 |
ENSP00000352121 | S353F | COSMIC | Skin Cancer | 21984974 |
ENSP00000419260 | G491E | COSMIC | Head and Neck Cancer | 21798897 |
ENSP00000352121 | C936S | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000392258 | S348I | COSMIC | Lung Cancer | 20668451 |
ENSP00000392258 | A445S | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000392258 | P526S | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000352121 | A621S | COSMIC | Gastric Cancer | 21097718 |
ENSP00000352121 | R839C | COSMIC | Pancreatic Cancer | |
ENSP00000392258 | R839C | COSMIC | Pancreatic Cancer | |
ENSP00000352121 | E740K | COSMIC | Breast Cancer | 20668451 |
ENSP00000352121 | L379I | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000392258 | R552C | TCGA | Neoplasms by Histologic Type | 21720365, 18772890 |
ENSP00000419260 | A621S | COSMIC | Gastric Cancer | 21097718 |
ENSP00000392258 | V616D | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000392258 | L379I | TCGA | Ovarian Cancer | 21720365, 18772890 |
ENSP00000392258 | D161E | COSMIC | Lung Cancer | 20668451 |
ENSP00000419260 | S760R | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000419260 | R90W | COSMIC | Gastric Cancer | 21097718 |
ENSP00000419260 | G966W | COSMIC | Lung Cancer | 18948947 |
ENSP00000392258 | S446F | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000352121 | A445V | BIOMART | Neoplasms by Histologic Type | 21930507, 21930502 |
ENSP00000352121 | A666D | COSMIC | Skin Cancer | 21984974 |
ENSP00000419260 | E602V | COSMIC | Lung Cancer | 20668451 |
ENSP00000419260 | R552C | TCGA | Neoplasms by Histologic Type | 21720365, 18772890 |
ENSP00000352121 | G491V | Ding2008, BIOMART | Lung Cancer | 18948947, 21930507, 21930502 |
ENSP00000419260 | S446F | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000419260 | P1004L | TCGA | Neoplasms by Histologic Type | 21720365, 18772890 |
ENSP00000352121 | R552C | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000392258 | K364N | COSMIC | Lung Cancer | 20668451 |
ENSP00000352121 | C936S | TCGA | Neoplasms by Histologic Type | 21720365, 18772890 |
ENSP00000419260 | R1021S | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000392258 | C936S | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000392258 | G966W | COSMIC | Lung Cancer | 18948947 |
ENSP00000352121 | G426E | COSMIC | Lung Cancer | |
ENSP00000392258 | R90W | COSMIC | Gastric Cancer | 21097718 |
ENSP00000392258 | G426E | COSMIC | Lung Cancer | |
ENSP00000419260 | R18Q | TCGA | Neoplasms by Histologic Type | 21720365, 18772890 |
ENSP00000392258 | P563R | COSMIC | Lung Cancer | 18948947 |
ENSP00000352121 | G491E | COSMIC | Head and Neck Cancer | 21798897 |
ENSP00000352121 | R90W | COSMIC | Gastric Cancer | 21097718 |
ENSP00000352121 | A445S | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000419260 | E511K | COSMIC | Lung Cancer | |
ENSP00000419260 | A445S | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000392258 | S760R | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000352121 | L58M | Ding2008, COSMIC | Lung Cancer | 18948947 |
ENSP00000392258 | T503M | COSMIC | Breast Cancer | 20668451 |
ENSP00000352121 | N66K | COSMIC | Lung Cancer | 20668451 |
ENSP00000419260 | P526S | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000392258 | N66K | COSMIC | Lung Cancer | 20668451 |
ENSP00000352121 | R18Q | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000419260 | R839C | COSMIC | Pancreatic Cancer | |
ENSP00000392258 | A621S | COSMIC | Gastric Cancer | 21097718 |
ENSP00000419260 | L379I | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000392258 | R1021S | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000392258 | L58M | COSMIC | Lung Cancer | 18948947 |
ENSP00000352121 | T1024K | TCGA | Neoplasms by Histologic Type | 21720365, 18772890 |
ENSP00000419260 | G426E | COSMIC | Lung Cancer | |
ENSP00000352121 | R542W | COSMIC | Breast Cancer | 20668451 |
ENSP00000392258 | R18Q | TCGA | Neoplasms by Histologic Type | 21720365, 18772890 |
ENSP00000352121 | R552C | TCGA | Neoplasms by Histologic Type | 21720365, 18772890 |
ENSP00000352121 | S446F | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000352121 | P1004L | TCGA | Neoplasms by Histologic Type | 21720365, 18772890 |
ENSP00000392258 | P1004L | COSMIC | Skin Cancer | 21984974 |
ENSP00000419260 | E740K | COSMIC | Breast Cancer | 20668451 |
ENSP00000392258 | T1024K | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000419260 | D161E | COSMIC | Lung Cancer | 20668451 |
ENSP00000392258 | R542W | COSMIC | Breast Cancer | 20668451 |
ENSP00000352121 | P1004L | COSMIC | Skin Cancer | 21984974 |
ENSP00000352121 | P526S | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000419260 | T503M | COSMIC | Breast Cancer | 20668451 |
ENSP00000352121 | L843H | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000352121 | E511K | COSMIC | Lung Cancer | |
ENSP00000419260 | S348I | COSMIC | Lung Cancer | 20668451 |
ENSP00000392258 | L843H | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000352121 | R1021S | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000419260 | R542W | COSMIC | Breast Cancer | 20668451 |
ENSP00000419260 | T1024K | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000419260 | P1004L | COSMIC | Skin Cancer | 21984974 |
ENSP00000419260 | A666D | COSMIC | Skin Cancer | 21984974 |
ENSP00000419260 | N66K | COSMIC | Lung Cancer | 20668451 |
ENSP00000352121 | L379I | TCGA | Ovarian Cancer | 21720365, 18772890 |
ENSP00000419260 | R18Q | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000392258 | S760R | TCGA | Ovarian Cancer | 21720365, 18772890 |
ENSP00000352121 | R178L | COSMIC | Lung Cancer | 20668451 |
ENSP00000392258 | A666D | COSMIC | Skin Cancer | 21984974 |
ENSP00000392258 | S353F | COSMIC | Skin Cancer | 21984974 |
ENSP00000419260 | S760R | TCGA | Ovarian Cancer | 21720365, 18772890 |
ENSP00000419260 | C936S | COSMIC | Central Nervous System Neoplasms | 18772890 |
ENSP00000352121 | V616D | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000392258 | C936S | TCGA | Neoplasms by Histologic Type | 21720365, 18772890 |
Differential expressed protein |
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|---|---|---|---|---|---|
ENSP00000352121 | Neoplasms by Histologic Type | Treatment (none vs. SB203580 treatment 3 hour) | cell line | Down | 0.36 | 15169874 |
Hyperphosphorylation site |
PK3CG_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
GBG3_HUMAN | PK3CG_HUMAN | Gprotein -> effector | gpDB |
GBB2_HUMAN | PK3CG_HUMAN | Gprotein -> effector | gpDB |
GBG12_HUMAN | PK3CG_HUMAN | Gprotein -> effector | gpDB |
GBG8_HUMAN | PK3CG_HUMAN | Gprotein -> effector | gpDB |
GBG11_HUMAN | PK3CG_HUMAN | Gprotein -> effector | gpDB |
GBG1_HUMAN | PK3CG_HUMAN | Gprotein -> effector | gpDB |
GBB3_HUMAN | PK3CG_HUMAN | Gprotein -> effector | gpDB |
GBG10_HUMAN | PK3CG_HUMAN | Gprotein -> effector | gpDB |
GNAQ_HUMAN | PK3CG_HUMAN | Gprotein -> effector | gpDB |
GBG13_HUMAN | PK3CG_HUMAN | Gprotein -> effector | gpDB |
GBB1_HUMAN | PK3CG_HUMAN | Gprotein -> effector | gpDB |
GBB5_HUMAN | PK3CG_HUMAN | Gprotein -> effector | gpDB |
GBG5_HUMAN | PK3CG_HUMAN | Gprotein -> effector | gpDB |
GBG2_HUMAN | PK3CG_HUMAN | Gprotein -> effector | gpDB |
PI3R4_HUMAN | PK3CG_HUMAN | kinase -> substrate | RegPhos |
ZAGL2_HUMAN | PK3CG_HUMAN | kinase -> substrate | RegPhos |
PK3CG_HUMAN | TPM2_HUMAN | kinase -> substrate | HPRD |
Function Annotation |
KEGG Pathway |
KEGG ID | Pathway |
---|---|
hsa05222 | Small cell lung cancer |
hsa04666 | Fc gamma R-mediated phagocytosis |
hsa05164 | Influenza A |
hsa04722 | Neurotrophin signaling pathway |
hsa04210 | Apoptosis |
hsa04662 | B cell receptor signaling pathway |
hsa04070 | Phosphatidylinositol signaling system |
hsa05162 | Measles |
hsa05166 | HTLV-I infection |
hsa05100 | Bacterial invasion of epithelial cells |
hsa04380 | Osteoclast differentiation |
hsa05221 | Acute myeloid leukemia |
hsa04664 | Fc epsilon RI signaling pathway |
hsa04630 | Jak-STAT signaling pathway |
hsa00562 | Inositol phosphate metabolism |
hsa04370 | VEGF signaling pathway |
hsa05200 | Pathways in cancer |
hsa05220 | Chronic myeloid leukemia |
hsa04910 | Insulin signaling pathway |
hsa05211 | Renal cell carcinoma |
hsa04973 | Carbohydrate digestion and absorption |
hsa04012 | ErbB signaling pathway |
hsa05160 | Hepatitis C |
hsa05145 | Toxoplasmosis |
hsa04150 | mTOR signaling pathway |
hsa05142 | Chagas disease (American trypanosomiasis) |
hsa05218 | Melanoma |
hsa04620 | Toll-like receptor signaling pathway |
hsa04650 | Natural killer cell mediated cytotoxicity |
hsa04930 | Type II diabetes mellitus |
hsa05213 | Endometrial cancer |
hsa05212 | Pancreatic cancer |
hsa05214 | Glioma |
hsa04960 | Aldosterone-regulated sodium reabsorption |
hsa04062 | Chemokine signaling pathway |
hsa05146 | Amoebiasis |
hsa04660 | T cell receptor signaling pathway |
hsa05223 | Non-small cell lung cancer |
hsa05215 | Prostate cancer |
hsa05210 | Colorectal cancer |
hsa04810 | Regulation of actin cytoskeleton |
hsa04725 | Cholinergic synapse |
hsa05203 | Viral carcinogenesis |
hsa04670 | Leukocyte transendothelial migration |
hsa05169 | Epstein-Barr virus infection |
hsa04510 | Focal adhesion |
hsa04914 | Progesterone-mediated oocyte maturation |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0043406 | positive regulation of MAP kinase activity | IDA | biological_process |
GO:0042110 | T cell activation | TAS | biological_process |
GO:0045087 | innate immune response | TAS | biological_process |
GO:0001816 | cytokine production | TAS | biological_process |
GO:0032252 | secretory granule localization | IEA | biological_process |
GO:0005488 | binding | IEA | molecular_function |
GO:0006897 | endocytosis | IEA | biological_process |
GO:0043303 | mast cell degranulation | TAS | biological_process |
GO:0004672 | protein kinase activity | TAS | molecular_function |
GO:0001525 | angiogenesis | IEA | biological_process |
GO:0006468 | protein phosphorylation | IEA | biological_process |
GO:0048015 | phosphatidylinositol-mediated signaling | IEA | biological_process |
GO:0005829 | cytosol | TAS | cellular_component |
GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic proc | IEA | biological_process |
GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase act | IEA | molecular_function |
GO:0002679 | respiratory burst involved in defense response | TAS | biological_process |
GO:0014065 | phosphatidylinositol 3-kinase cascade | IDA | biological_process |
GO:0002407 | dendritic cell chemotaxis | TAS | biological_process |
GO:0010818 | T cell chemotaxis | TAS | biological_process |
GO:0055118 | negative regulation of cardiac muscle contraction | TAS | biological_process |
GO:0002675 | positive regulation of acute inflammatory response | IEA | biological_process |
GO:0005886 | plasma membrane | IEA | cellular_component |
GO:0097284 | hepatocyte apoptotic process | IEA | biological_process |
GO:0030168 | platelet activation | TAS | biological_process |
GO:0035747 | natural killer cell chemotaxis | TAS | biological_process |
GO:0016773 | phosphotransferase activity, alcohol group as acce | IEA | molecular_function |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0030593 | neutrophil chemotaxis | TAS | biological_process |
GO:0042098 | T cell proliferation | TAS | biological_process |
GO:0007596 | blood coagulation | TAS | biological_process |
GO:0005944 | 1-phosphatidylinositol-4-phosphate 3-kinase, class | IDA | cellular_component |
GO:0006954 | inflammatory response | TAS | biological_process |
GO:0016303 | 1-phosphatidylinositol-3-kinase activity | IEA | molecular_function |
GO:0016020 | membrane | IDA | cellular_component |
GO:0005942 | phosphatidylinositol 3-kinase complex | IEA | cellular_component |
GO:0005524 | ATP binding | IEA | molecular_function |
GO:0051897 | positive regulation of protein kinase B signaling | IDA | biological_process |
GO:0007186 | G-protein coupled receptor signaling pathway | IDA | biological_process |
GO:0033628 | regulation of cell adhesion mediated by integrin | TAS | biological_process |
GO:0007204 | elevation of cytosolic calcium ion concentration | IEA | biological_process |
GO:0010897 | negative regulation of triglyceride catabolic proc | IEA | biological_process |
GO:0016772 | transferase activity, transferring phosphorus-cont | IEA | molecular_function |
GO:0044281 | small molecule metabolic process | TAS | biological_process |
GO:0006644 | phospholipid metabolic process | TAS | biological_process |
GO:0005737 | cytoplasm | IDA | cellular_component |
GO:0006661 | phosphatidylinositol biosynthetic process | TAS | biological_process |
GO:0043066 | negative regulation of apoptotic process | IEA | biological_process |
GO:0002250 | adaptive immune response | TAS | biological_process |
GO:0072672 | neutrophil extravasation | TAS | biological_process |
GO:0004674 | protein serine/threonine kinase activity | IEA | molecular_function |
GO:0070527 | platelet aggregation | TAS | biological_process |
GO:0035004 | phosphatidylinositol 3-kinase activity | TAS | molecular_function |
GO:0046875 | ephrin receptor binding | IPI | molecular_function |